nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—Urinary incontinence—Valrubicin—urinary bladder cancer	0.0453	0.0453	CcSEcCtD
Sufentanil—Shivering—Gemcitabine—urinary bladder cancer	0.0367	0.0367	CcSEcCtD
Sufentanil—Urinary retention—Valrubicin—urinary bladder cancer	0.0323	0.0323	CcSEcCtD
Sufentanil—Injection site pain—Thiotepa—urinary bladder cancer	0.0199	0.0199	CcSEcCtD
Sufentanil—Laryngospasm—Etoposide—urinary bladder cancer	0.0156	0.0156	CcSEcCtD
Sufentanil—Erythema—Mitomycin—urinary bladder cancer	0.0141	0.0141	CcSEcCtD
Sufentanil—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0138	0.0138	CcSEcCtD
Sufentanil—Apnoea—Etoposide—urinary bladder cancer	0.0138	0.0138	CcSEcCtD
Sufentanil—Body temperature increased—Valrubicin—urinary bladder cancer	0.0132	0.0132	CcSEcCtD
Sufentanil—Body temperature increased—Carboplatin—urinary bladder cancer	0.0122	0.0122	CcSEcCtD
Sufentanil—Hypertension—Mitomycin—urinary bladder cancer	0.0122	0.0122	CcSEcCtD
Sufentanil—Pruritus—Valrubicin—urinary bladder cancer	0.0118	0.0118	CcSEcCtD
Sufentanil—Confusional state—Mitomycin—urinary bladder cancer	0.0116	0.0116	CcSEcCtD
Sufentanil—Euphoric mood—Fluorouracil—urinary bladder cancer	0.0115	0.0115	CcSEcCtD
Sufentanil—Cardiac arrest—Thiotepa—urinary bladder cancer	0.0112	0.0112	CcSEcCtD
Sufentanil—Urinary retention—Thiotepa—urinary bladder cancer	0.0112	0.0112	CcSEcCtD
Sufentanil—Dizziness—Valrubicin—urinary bladder cancer	0.0111	0.0111	CcSEcCtD
Sufentanil—Vomiting—Valrubicin—urinary bladder cancer	0.0106	0.0106	CcSEcCtD
Sufentanil—Rash—Valrubicin—urinary bladder cancer	0.0105	0.0105	CcSEcCtD
Sufentanil—Dermatitis—Valrubicin—urinary bladder cancer	0.0105	0.0105	CcSEcCtD
Sufentanil—Headache—Valrubicin—urinary bladder cancer	0.0105	0.0105	CcSEcCtD
Sufentanil—Somnolence—Mitomycin—urinary bladder cancer	0.0102	0.0102	CcSEcCtD
Sufentanil—Nausea—Valrubicin—urinary bladder cancer	0.00993	0.00993	CcSEcCtD
Sufentanil—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00949	0.00949	CcSEcCtD
Sufentanil—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.00927	0.00927	CcSEcCtD
Sufentanil—Body temperature increased—Mitomycin—urinary bladder cancer	0.00911	0.00911	CcSEcCtD
Sufentanil—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00843	0.00843	CcSEcCtD
Sufentanil—Apnoea—Methotrexate—urinary bladder cancer	0.00824	0.00824	CcSEcCtD
Sufentanil—Urinary tract disorder—Thiotepa—urinary bladder cancer	0.00805	0.00805	CcSEcCtD
Sufentanil—Cardiac arrest—Etoposide—urinary bladder cancer	0.00805	0.00805	CcSEcCtD
Sufentanil—Injection site pain—Epirubicin—urinary bladder cancer	0.00801	0.00801	CcSEcCtD
Sufentanil—Urethral disorder—Thiotepa—urinary bladder cancer	0.00799	0.00799	CcSEcCtD
Sufentanil—Dizziness—Mitomycin—urinary bladder cancer	0.00762	0.00762	CcSEcCtD
Sufentanil—Injection site pain—Doxorubicin—urinary bladder cancer	0.00741	0.00741	CcSEcCtD
Sufentanil—Vomiting—Mitomycin—urinary bladder cancer	0.00732	0.00732	CcSEcCtD
Sufentanil—Chills—Thiotepa—urinary bladder cancer	0.00732	0.00732	CcSEcCtD
Sufentanil—Arrhythmia—Thiotepa—urinary bladder cancer	0.00728	0.00728	CcSEcCtD
Sufentanil—Rash—Mitomycin—urinary bladder cancer	0.00726	0.00726	CcSEcCtD
Sufentanil—Dermatitis—Mitomycin—urinary bladder cancer	0.00726	0.00726	CcSEcCtD
Sufentanil—Headache—Mitomycin—urinary bladder cancer	0.00722	0.00722	CcSEcCtD
Sufentanil—Bronchospasm—Etoposide—urinary bladder cancer	0.0072	0.0072	CcSEcCtD
Sufentanil—Erythema—Thiotepa—urinary bladder cancer	0.0071	0.0071	CcSEcCtD
Sufentanil—Nausea—Mitomycin—urinary bladder cancer	0.00684	0.00684	CcSEcCtD
Sufentanil—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.00677	0.00677	CcSEcCtD
Sufentanil—Urethral disorder—Gemcitabine—urinary bladder cancer	0.00672	0.00672	CcSEcCtD
Sufentanil—Bradycardia—Cisplatin—urinary bladder cancer	0.00651	0.00651	CcSEcCtD
Sufentanil—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.00631	0.00631	CcSEcCtD
Sufentanil—Urethral disorder—Cisplatin—urinary bladder cancer	0.00627	0.00627	CcSEcCtD
Sufentanil—Chills—Gemcitabine—urinary bladder cancer	0.00615	0.00615	CcSEcCtD
Sufentanil—Hypertension—Thiotepa—urinary bladder cancer	0.00613	0.00613	CcSEcCtD
Sufentanil—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00613	0.00613	CcSEcCtD
Sufentanil—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00602	0.00602	CcSEcCtD
Sufentanil—Erythema—Gemcitabine—urinary bladder cancer	0.00597	0.00597	CcSEcCtD
Sufentanil—Erythema—Fluorouracil—urinary bladder cancer	0.00587	0.00587	CcSEcCtD
Sufentanil—Confusional state—Thiotepa—urinary bladder cancer	0.00584	0.00584	CcSEcCtD
Sufentanil—Urinary tract disorder—Etoposide—urinary bladder cancer	0.00578	0.00578	CcSEcCtD
Sufentanil—Urethral disorder—Etoposide—urinary bladder cancer	0.00574	0.00574	CcSEcCtD
Sufentanil—Arrhythmia—Cisplatin—urinary bladder cancer	0.00571	0.00571	CcSEcCtD
Sufentanil—Tachycardia—Thiotepa—urinary bladder cancer	0.00565	0.00565	CcSEcCtD
Sufentanil—Erythema—Cisplatin—urinary bladder cancer	0.00557	0.00557	CcSEcCtD
Sufentanil—Chills—Etoposide—urinary bladder cancer	0.00526	0.00526	CcSEcCtD
Sufentanil—Hypertension—Gemcitabine—urinary bladder cancer	0.00516	0.00516	CcSEcCtD
Sufentanil—Somnolence—Thiotepa—urinary bladder cancer	0.00515	0.00515	CcSEcCtD
Sufentanil—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00487	0.00487	CcSEcCtD
Sufentanil—Confusional state—Fluorouracil—urinary bladder cancer	0.00483	0.00483	CcSEcCtD
Sufentanil—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00479	0.00479	CcSEcCtD
Sufentanil—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00477	0.00477	CcSEcCtD
Sufentanil—Tachycardia—Fluorouracil—urinary bladder cancer	0.00468	0.00468	CcSEcCtD
Sufentanil—Body temperature increased—Thiotepa—urinary bladder cancer	0.00458	0.00458	CcSEcCtD
Sufentanil—Hypotension—Gemcitabine—urinary bladder cancer	0.00455	0.00455	CcSEcCtD
Sufentanil—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00454	0.00454	CcSEcCtD
Sufentanil—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00451	0.00451	CcSEcCtD
Sufentanil—Hypotension—Fluorouracil—urinary bladder cancer	0.00448	0.00448	CcSEcCtD
Sufentanil—Tachycardia—Cisplatin—urinary bladder cancer	0.00443	0.00443	CcSEcCtD
Sufentanil—Hypertension—Etoposide—urinary bladder cancer	0.0044	0.0044	CcSEcCtD
Sufentanil—Somnolence—Gemcitabine—urinary bladder cancer	0.00433	0.00433	CcSEcCtD
Sufentanil—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00427	0.00427	CcSEcCtD
Sufentanil—Somnolence—Fluorouracil—urinary bladder cancer	0.00426	0.00426	CcSEcCtD
Sufentanil—Hypotension—Cisplatin—urinary bladder cancer	0.00424	0.00424	CcSEcCtD
Sufentanil—Confusional state—Etoposide—urinary bladder cancer	0.0042	0.0042	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00418	0.00418	CcSEcCtD
Sufentanil—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00416	0.00416	CcSEcCtD
Sufentanil—Pruritus—Thiotepa—urinary bladder cancer	0.0041	0.0041	CcSEcCtD
Sufentanil—Tachycardia—Etoposide—urinary bladder cancer	0.00406	0.00406	CcSEcCtD
Sufentanil—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00402	0.00402	CcSEcCtD
Sufentanil—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00395	0.00395	CcSEcCtD
Sufentanil—Hypotension—Etoposide—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Sufentanil—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00385	0.00385	CcSEcCtD
Sufentanil—Dizziness—Thiotepa—urinary bladder cancer	0.00383	0.00383	CcSEcCtD
Sufentanil—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00379	0.00379	CcSEcCtD
Sufentanil—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00374	0.00374	CcSEcCtD
Sufentanil—Somnolence—Etoposide—urinary bladder cancer	0.0037	0.0037	CcSEcCtD
Sufentanil—Vomiting—Thiotepa—urinary bladder cancer	0.00368	0.00368	CcSEcCtD
Sufentanil—Rash—Thiotepa—urinary bladder cancer	0.00365	0.00365	CcSEcCtD
Sufentanil—Dermatitis—Thiotepa—urinary bladder cancer	0.00365	0.00365	CcSEcCtD
Sufentanil—Headache—Thiotepa—urinary bladder cancer	0.00363	0.00363	CcSEcCtD
Sufentanil—Body temperature increased—Cisplatin—urinary bladder cancer	0.00359	0.00359	CcSEcCtD
Sufentanil—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00353	0.00353	CcSEcCtD
Sufentanil—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00346	0.00346	CcSEcCtD
Sufentanil—Pruritus—Gemcitabine—urinary bladder cancer	0.00345	0.00345	CcSEcCtD
Sufentanil—Nausea—Thiotepa—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Sufentanil—Urethral disorder—Methotrexate—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Sufentanil—Feeling abnormal—Etoposide—urinary bladder cancer	0.00343	0.00343	CcSEcCtD
Sufentanil—Pruritus—Fluorouracil—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Sufentanil—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Sufentanil—Bradycardia—Epirubicin—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Sufentanil—Body temperature increased—Etoposide—urinary bladder cancer	0.00329	0.00329	CcSEcCtD
Sufentanil—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Sufentanil—Urethral disorder—Epirubicin—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Sufentanil—Dizziness—Fluorouracil—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Sufentanil—Chills—Methotrexate—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Sufentanil—Vomiting—Gemcitabine—urinary bladder cancer	0.0031	0.0031	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Sufentanil—Rash—Gemcitabine—urinary bladder cancer	0.00307	0.00307	CcSEcCtD
Sufentanil—Dermatitis—Gemcitabine—urinary bladder cancer	0.00307	0.00307	CcSEcCtD
Sufentanil—Hypersensitivity—Etoposide—urinary bladder cancer	0.00307	0.00307	CcSEcCtD
Sufentanil—Erythema—Methotrexate—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Sufentanil—Headache—Gemcitabine—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Sufentanil—Vomiting—Fluorouracil—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Sufentanil—Rash—Fluorouracil—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Sufentanil—Dermatitis—Fluorouracil—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Sufentanil—Headache—Fluorouracil—urinary bladder cancer	0.003	0.003	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.003	0.003	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00298	0.00298	CcSEcCtD
Sufentanil—Chills—Epirubicin—urinary bladder cancer	0.00295	0.00295	CcSEcCtD
Sufentanil—Pruritus—Etoposide—urinary bladder cancer	0.00294	0.00294	CcSEcCtD
Sufentanil—Arrhythmia—Epirubicin—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Sufentanil—Nausea—Gemcitabine—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Sufentanil—Vomiting—Cisplatin—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Sufentanil—Rash—Cisplatin—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Sufentanil—Dermatitis—Cisplatin—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Sufentanil—Erythema—Epirubicin—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Sufentanil—Nausea—Fluorouracil—urinary bladder cancer	0.00285	0.00285	CcSEcCtD
Sufentanil—Dizziness—Etoposide—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Sufentanil—Chills—Doxorubicin—urinary bladder cancer	0.00273	0.00273	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Sufentanil—Nausea—Cisplatin—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Sufentanil—Vomiting—Etoposide—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Sufentanil—Rash—Etoposide—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Sufentanil—Dermatitis—Etoposide—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Sufentanil—Headache—Etoposide—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Sufentanil—Confusional state—Methotrexate—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Sufentanil—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Sufentanil—Nausea—Etoposide—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Sufentanil—Hypertension—Epirubicin—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Sufentanil—Confusional state—Epirubicin—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Sufentanil—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Sufentanil—Hypotension—Methotrexate—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Sufentanil—Tachycardia—Epirubicin—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Sufentanil—Somnolence—Methotrexate—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Sufentanil—Hypotension—Epirubicin—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Sufentanil—Somnolence—Epirubicin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Sufentanil—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Sufentanil—Body temperature increased—Methotrexate—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Sufentanil—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Sufentanil—Body temperature increased—Epirubicin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Sufentanil—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Sufentanil—Pruritus—Methotrexate—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Sufentanil—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Sufentanil—Pruritus—Epirubicin—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Sufentanil—Dizziness—Methotrexate—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Sufentanil—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Sufentanil—Vomiting—Methotrexate—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Sufentanil—Rash—Methotrexate—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Sufentanil—Dermatitis—Methotrexate—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Sufentanil—Headache—Methotrexate—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Sufentanil—Dizziness—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Sufentanil—Vomiting—Epirubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Sufentanil—Nausea—Methotrexate—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Sufentanil—Rash—Epirubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Sufentanil—Dermatitis—Epirubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Sufentanil—Headache—Epirubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Sufentanil—Nausea—Epirubicin—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Sufentanil—Rash—Doxorubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Sufentanil—Headache—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
